Journal
ADVANCED MATERIALS
Volume 33, Issue 16, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202008451
Keywords
alginate hydrogel; cartilage repair; IGF‐ I; perifocal osteoarthritis; rAAV
Categories
Funding
- Deutsche Arthrose-Hilfe e.V.
- Saarland University
- Projekt DEAL
Ask authors/readers for more resources
In this study, gene therapy using an alginate hydrogel as a carrier for the delivery of the IGF-I gene was found to enhance cartilage repair in a minipig model. The sustained overexpression of IGF-I significantly improved parameters of cartilage repair and reduced perifocal osteoarthritis and inflammation after one year of treatment, demonstrating the potential clinical application of biomaterial-guided gene therapy for promoting cartilage repair and protecting against OA.
The regeneration of focal articular cartilage defects is complicated by the reduced quality of the repair tissue and the potential development of perifocal osteoarthritis (OA). Biomaterial-guided gene therapy may enhance cartilage repair by controlling the release of therapeutic sequences in a spatiotemporal manner. Here, the benefits of delivering a recombinant adeno-associated virus (rAAV) vector coding for the human insulin-like growth factor I (IGF-I) via an alginate hydrogel (IGF-I/AlgPH155) to enhance repair of full-thickness chondral defects following microfracture surgery after one year in minipigs versus control (lacZ/AlgPH155) treatment are reported. Sustained IGF-I overexpression is significantly achieved in the repair tissue of defects treated with IGF-I/AlgPH155 versus those receiving lacZ/AlgPH155 for one year and in the cartilage surrounding the defects. Administration of IGF-I/AlgPH155 significantly improves parameters of cartilage repair at one year relative to lacZ/AlgPH155 (semiquantitative total histological score, cell densities, matrix deposition) without deleterious or immune reactions. Remarkably, delivery of IGF-I/AlgPH155 also significantly reduces perifocal OA and inflammation after one year versus lacZ/AlgPH155 treatment. Biomaterial-guided rAAV gene transfer represents a valuable clinical approach to promote cartilage repair and to protect against OA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available